首页> 美国卫生研究院文献>Molecular Medicine Reports >Endothelial progenitor cell dysfunction in acute exacerbation of chronic obstructive pulmonary disease
【2h】

Endothelial progenitor cell dysfunction in acute exacerbation of chronic obstructive pulmonary disease

机译:内皮祖细胞功能障碍在慢性阻塞性肺疾病急性加重中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Endothelial progenitor cells (EPCs) are decreased in cardiac dysfunction morbidity associated with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Therefore, the present study aimed to assess the role of EPCs in AECOPD. Patients with AECOPD (n=27) or stable COPD (n=26) were enrolled. Systemic inflammatory markers (high-sensitivity C-reactive protein) were measured. In addition, EPCs were counted, isolated and cultured, and their proliferative, migratory, adhesive and tube-forming capabilities were determined, in cells from patients with AECOPD and stable COPD. EPC number was lower in patients with AECOPD (5.1±2.6×103/ml) compared with patients with stable COPD (6.0±3.2×103/ml). Migration assay indicated that the early-EPCs isolated from patients with AECOPD were significantly less mobile than EPCs derived from stable COPD subjects, at a stromal-cell derived factor-1α concentration of 100 ng/ml (3,550/30,000 vs. 7,853/30,000, P<0.05). C-X-C chemokine receptor-4 positivity was significantly reduced in AECOPD patients (16.1±9.9 vs. 56.33±6.3%, P<0.05). Furthermore, fewer early-EPC clusters were formed by EPCs derived from AECOPD, compared with those derived from stable COPD (8.2±0.86 vs. 14.4±1.36, P=0.027). Stable COPD late-EPCs were markedly deficient in intact tubule formation, however AECOPD late-EPCs formed no tubules. The number of AECOPD- and stable COPD-derived late-EPCs adhering to Matrigel-induced tubules was 36.8±1.85 and 20.6±1.36 (P<0.05) respectively, and the cluster of differentiation 31 positivity in late-EPCs was 79.69±1.3 and 29.1±2.47%, in AECOPD and stable COPD patients, respectively (P<0.001). The findings demonstrated that early-EPCs are decreased and dysfunctional in AECOPD patients, which may contribute to the altered vascular endothelium in this patient population.
机译:内皮祖细胞(EPC)与慢性阻塞性肺疾病(AECOPD)急性加重相关的心功能不全发病率降低。因此,本研究旨在评估EPC在AECOPD中的作用。纳入AECOPD(n = 27)或稳定COPD(n = 26)的患者。测量全身炎症标志物(高敏C反应蛋白)。此外,在来自AECOPD和稳定COPD患者的细胞中,对EPC进行了计数,分离和培养,并确定了它们的增殖,迁移,粘附和成管能力。与稳定COPD患者(6.0±3.2×10 3 / ml)相比,AECOPD患者的EPC数较低(5.1±2.6×10 3 / ml)。迁移分析表明,在基质细胞衍生因子-1α浓度为100 ng / ml的情况下,从AECOPD患者中分离出的早期EPC的活动性远低于稳定COPD受试者的EPC(3,550 / 30,000对7,853 / 30,000, P <0.05)。 AECOPD患者的C-X-C趋化因子受体4阳性率显着降低(16.1±9.9 vs. 56.33±6.3%,P <0.05)。此外,与稳定COPD衍生的EPC相比,由AECOPD衍生的EPC形成的早期EPC簇更少(8.2±0.86 vs. 14.4±1.36,P = 0.027)。稳定的COPD晚期EPC在完整的肾小管形成方面明显不足,但是AECOPD晚期EPC没有形成小管。粘附于基质胶诱导的肾小管的AECOPD和稳定的COPD衍生的晚期EPC的数目分别为36.8±1.85和20.6±1.36(P <0.05),并且晚期EPC中分化31阳性的簇为79.69±1.3和AECOPD患者和稳定的COPD患者分别为29.1±2.47%(P <0.001)。研究结果表明,AECOPD患者早期EPC减少且功能异常,这可能导致该患者人群中的血管内皮改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号